Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Apr 28, 2015; 21(16): 4933-4945
Published online Apr 28, 2015. doi: 10.3748/wjg.v21.i16.4933
Table 1 Characteristics of hepatocellular carcinoma patients with hepatitis B virus infection
VariablesAll patients (n = 105)LL group (n = 55)HL group (n = 34)HH group (n = 16)P value
Age (yr)62 (57-68)62 (59-66)64 (56-70)63 (56-70)0.962
Sex, male/female90/1548/729/513/30.829
Body mass index (kg/m2)23.7 ± 3.124.0 ± 2.623.5 ± 3.323.1 ± 4.30.691
Open/pure lap/lap-assisted83/8/1443/6/629/1/411/1/40.390
Hr
0/S/1/2/350/25/14/14/234/13/6/2/014/10/4/4/22/2/4/8/0< 0.001
Preoperative laboratory values
Aspartate transaminase (U/L)31 (22-46)31 (22-41)30 (25-48)43 (24-62)0.153
Alanine transaminase (U/L)29 (20-39)32 (17-42)27 (21-42)27 (19-52)0.978
Platelets (× 104/μL)16.6 ± 13.316.4 ± 12.716.2 ± 16.218.0 ± 8.60.168
Serum ALB (g/dL)3.95 ± 0.463.99 ± 0.463.87 ± 0.433.98 ± 0.530.334
PT (%)93.3 ± 12.295.5 ± 11.190.3 ± 14.192.2 ± 10.60.062
Serum TBIL (mg/dL)0.79 ± 0.440.80 ± 0.450.85 ± 0.490.65 ± 0.240.681
ICGR159.6 (5.7-14.9)9.4 (5.9-14.0)12.5 (5.7-22.5)8.5 (5.0-14.6)0.334
AFP (ng/mL)24.2 (3.8-165.0)5.2 (2.4-31.1)45.0 (5.1-246.5)1950 (753.5-2827.0)< 0.001
DCP (mAU/mL)38 (20-364)22 (15-28)399 (90-1,667)4460 (223-34373)< 0.001
Intraoperative data
Blood loss (mL)400 (130-660)360 (110-560)435 (100-1,040)880 (130-1330)0.042
Surgical duration (min)332 (243-411)313 (236-370)361 (243-450)432 (270-604)0.020
Blood transfusion
RCC: yes/no (%)21/84 (20.0%)4/51 (7.2%)10/24 (29.4%)7/9 (43.8%)0.001
Pathological results
Tumor size (cm)4.27 ± 3.213.26 ± 2.564.97 ± 2.716.24 ± 4.77< 0.001
Multiple tumors: yes/no (%)39/66 (37.1%)19/36 (34.5%)15/19 (44.1%)5/11 (31.3%)0.575
Vascular invasion: yes/no (%)34/71 (32.4%)10/45 (18.2%)14/20 (41.1%)10/6 (62.5%)0.002
Remnant liver: NL/CH/LC13/47/416/23/263/17/144/7/50.464
Histological tumor differentiation
Well/moderately/poorly14/63/2811/35/93/18/130/10/60.048
Recurrence within 2 yr after liver resection
Yes/no (%)50/55 (47.6%)